 RAMSEY, N.J. and BOCA RATON, Fla., Oct. 01, 2021 GLOBE NEWSWIRE -- ADMA Biologics, Inc. Nasdaq: ADMA ADMA or the Company, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced an exclusive educational event at IDWeek 2021 on respiratory viral infections, presented by nationally recognized clinical experts Dr. Michael Ison from Northwestern University and Dr. Jolan Walter from the University of South Florida and Johns Hopkins All Childrens Hospital. Two leading experts in the management of respiratory syncytial virus RSV and other respiratory viruses in immunocompromised patients will discuss todays key clinical challenges and emerging treatment strategies. A novel intravenous immunoglobulin IVIG product with a unique composition will be introduced, including patient cases. 